Investigational new drugPeptide
Compound 61642
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061642
Risk Class
HIGH
Last Audit
May 21, 2108
Research Abstract
Peptide candidate engineered for endocrine support initiatives with automated dossier coverage.
Compound 61642 is a peptide asset inside peptide innovation track initiatives, optimized for endocrine support and performance longevity.
The dossier currently sits in investigational new drug with a high risk rating, meaning it is restricted to black-box teams with hardened compliance.
Supply records cite CAS AUTO-061642 with updates logged 2108-05-21.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Endocrine supportPerformance longevity
Nomenclature
CX-61642Peptide Program 61642
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061642
- [2] Operations Pulse • Peptide innovation track
- [3] Risk Governance Ledger • HIGH clearance for COMPOUND-61642